In July 2016 the Badminton World Federation (BWF) has reported an anti-doping rule violation against the Thai Athlete Ratchanok Intanon after her sample tested positive for the prohibited substance Triamcinolone.
After notification a provisional suspension was ordered and the Athlete accepted the test results.
The Athlete’s medical evidence together with the testimony from an expert witness estabilshed to the satisfaction of the Panel that the substance was administered in May 2016, before the competition as part of on‐going medical treatment of the athlete and that the route of administration of the substance was intra‐tendinous. The Panel concludes that for this mecical treatment no TUE was necessary.
Therefore the BWF Hearing Panel decides on 17 July 2016 that the Athlete did not commit an anti-doping rule violation.
